· 2022–2024 · DOL EFAST2
Search
Browse
Resources
Pricing
XENON PHARMACEUTICALS USA, INC — XENON PHARMACEUTICALS 401(K) PLAN, Form 5500 (2024) | Form 5500 Search
Back to filter
Original filing (PDF)
20250909091626NAL0020121105001
XENON PHARMACEUTICALS USA, INC
Form 5500-SF
FILING_RECEIVED
XENON PHARMACEUTICALS 401(K) PLAN
401(k) retirement plan
Signals · 1
No auditor on file
Active participants
136
Accounts w/ balance
135
Plan assets (EOY)
$7.6M
Net assets (EOY)
$7.6M
Plan health score (directional)
77
/ 100
Grade B
Above-average plan
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
60
Concentration risk
75
Total plan cost
75
Vendor stack
100
Participation health
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for
XENON PHARMACEUTICALS USA, INC
.
Find decision makers
Plan sponsor
Name
XENON PHARMACEUTICALS USA, INC
EIN
81-4576210
Address
117 KENDRICK STREET, SUITE 200 · NEEDHAM, MA · 02494
Phone
(604) 728-1228
Industry
Manufacturing
see all
Plan administrator
Name
PENETEGRA SERVICES, INC
EIN
13-3745616
City
CHARLOTTE, NC
Phone
(844) 367-2848
Plan characteristics
Plan number
001
Plan year
2024
Plan year begin
2024-01-01
Tax period
2024-12-31
Filed
2025-09-09
Pension benefit codes
2E · Profit-sharing
3D · Pre-approved plan (master / prototype / VS)
2G · Total participant-directed accounts
2J · 401(k) feature
2K · 401(m) arrangement
2R · Participant-directed brokerage (SDBA)
2F · ERISA section 404(c)
2T · Default investment account (QDIA)
Service providers (Schedule C)
Small plans don't disclose service providers
Related plans
Similar-size Manufacturing plans
SANISURE LLC
SANISURE LLC 401(K) PROFIT SHARING PLAN
$7.6M · 244 participants
EVOFEM, INC.
EVOFEM, INC. 401(K) PLAN
$7.5M · 32 participants
BOLT BIOTHERAPEUTICS, INC.
BOLT BIOTHERAPEUTICS, INC. 401(K) PROFIT SHARING PLAN
$7.7M · 51 participants
SHEFFIELD PHARMACEUTICALS, LLC
SHEFFIELD PHARMACEUTICALS, LLC RETIREMENT PLAN
$7.5M · 130 participants
CUMBERLAND PHARMACEUTICALS INC.
CUMBERLAND PHARMACEUTICALS 401(K) PLAN
$7.3M · 85 participants
100
Knocking points off
No independent qualified public accountant (IQPA) named.
Helping the score
Concentration not scored — Schedule of Assets PDF not yet parsed for this plan.
No Schedule C compensation disclosed — likely a small plan or unbundled.
Audit & trust (Schedule H)
Auditor
—
Trustee / custodian
—
Trustee phone
—
Small plan (5500-SF) — Schedule H data not available.
PRIMUS PHARMACEUTICALS INC
PRIMUS PHARMACEUTICALS INC 401(K) PROFIT SHARING PLAN & TRUST
$7.8M · 38 participants
Large plans in Massachusetts
FIDELITY MANAGEMENT TRUST COMPANY
FIDELITY GROWTH COMPANY COMMINGLED POOL
$91.5B
STATE STREET GLOBAL ADVISORS TRUST COMPANY
STATE STREET S&P 500(R) INDEX NON-LENDING SERIES FUND CLASS A
$91.0B
FIDELITY MANAGEMENT TRUST COMPANY
FIDELITY CONTRAFUND COMMINGLED POOL
$59.7B
STATE STREET GLOBAL ADVISORS TRUST COMPANY
STATE STREET S&P 500(R) INDEX SECURITIES LENDING SERIES FUND CLASS I
$53.6B
GEODE CAPITAL MANAGEMENT TRUST COMPANY, LLC
SPARTAN GROUP TRUST FOR EMPLOYEE BENEFIT PLANS SPARTAN 500 INDEX POOL
$47.6B
STATE STREET GLOBAL ADVISORS TRUST COMPANY
STATE STREET S&P 500(R) INDEX SECURITIES LENDING SERIES FUND CLASS II
$46.7B
